1-3 of 3
Keywords: acipimox
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Inhibition of carbohydrate-mediated glucagon-like peptide-I (7–36)amide secretion by circulating non-esterified fatty acids

L. RANGANATH, F. NORRIS, L. MORGAN, J. WRIGHT, V. MARKS
Journal: Clinical Science
Clin Sci (Lond) (1999) 96 (4): 335–342.
https://doi.org/10.1042/cs0960335
Published: 01 April 1999
... in obese subjects, confirming previous observations. In the second study, in which carbohydrate-stimulated GLP-1 responses were again evaluated in obese and lean women, circulating NEFA levels were modulated using either heparin (to increase serum NEFA) or acipimox (to reduce serum NEFA). Treatment...
View article titled, Inhibition of carbohydrate-mediated glucagon-like peptide-I (7–36)amide secretion by circulating non-esterified fatty acids
Open the PDF for Inhibition of carbohydrate-mediated glucagon-like peptide-I (7–36)amide secretion by circulating non-esterified fatty acids in another window
Articles

Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox

G. R. Fulcher, M. Walker, C. Catalano, M. Farrer, K. G. M. M. Alberti
Journal: Clinical Science
Clin Sci (Lond) (1992) 82 (5): 565–571.
https://doi.org/10.1042/cs0820565
Published: 01 May 1992
... and lipid oxidation rates are decreased, questioning the importance of this interaction to glycaemic control. We have therefore measured the acute changes that occur 120–150 min after administration of 500 mg of the anti-lipolytic agent acipimox in eight non-obese male patients with non-insulin-dependent...
View article titled, Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of <span class="search-highlight">acipimox</span>
Open the PDF for Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of <span class="search-highlight">acipimox</span> in another window
Articles

Effects of Acipimox, a Nicotinic Acid Derivative, on Lipolysis in Human Adipose Tissue and on Cholesterol Synthesis in Human Jejunal Mucosa

C. Stirling, M. McAleer, J. P. D. Reckless, R. R. Campbell, D. Mundy, D. J. Betteridge, K. Foster
Journal: Clinical Science
Clin Sci (Lond) (1985) 68 (1): 83–88.
https://doi.org/10.1042/cs0680083
Published: 01 January 1985
...C. Stirling; M. McAleer; J. P. D. Reckless; R. R. Campbell; D. Mundy; D. J. Betteridge; K. Foster 1. The mode of action of acipimox (5-methyl-pyrazine carboxylic acid 4-oxide), an hypotriglyceridaemic agent, was examined in human adipose tissue and intestinal mucosa. 2. The rates of release...
View article titled, Effects of <span class="search-highlight">Acipimox</span>, a Nicotinic Acid Derivative, on Lipolysis in Human Adipose Tissue and on Cholesterol Synthesis in Human Jejunal Mucosa
Open the PDF for Effects of <span class="search-highlight">Acipimox</span>, a Nicotinic Acid Derivative, on Lipolysis in Human Adipose Tissue and on Cholesterol Synthesis in Human Jejunal Mucosa in another window